Bile Duct Cancer (Cholangiocarcinoma) Pipeline Assessment 2018: Key-Players - PCI Biotech AS, Delcath Systems Inc, Merck Sharp & Dohme Corp, Aslan Pharmaceuticals
Bile Duct Cancer (Cholangiocarcinoma) Pipeline insight report provides comprehensive insights of the ongoing therapeutic research and development. This Pipeline insight report provides pipeline product profiles which include product description, developmental activities, licensors & collaborators and chemical information.
View full press release